Clinical efficacy of Chinese medicine envelope therapy combined with anti-tuberculosis drug regimen in the treatment of tuberculous peritonitis and its effects on the level of inflammatory mediators

LI Yanpeng; JING Fengying; ZHANG Yan; QIU Zheng; WANG Fan; MA Xiying; SHAO Xiaoxia; NAN Ya

doi:10.16025/j.1674-1307.2026.03.008

您当前的位置：

首页 >

文章列表页 >

Clinical efficacy of Chinese medicine envelope therapy combined with anti-tuberculosis drug regimen in the treatment of tuberculous peritonitis and its effects on the level of inflammatory mediators

更新时间：2026-06-02

- Clinical efficacy of Chinese medicine envelope therapy combined with anti-tuberculosis drug regimen in the treatment of tuberculous peritonitis and its effects on the level of inflammatory mediators
- Beijing Journal of Traditional Chinese Medicine Vol. 45, Issue 3, Pages: 328-332(2026)
- 作者机构：
  
  陕西省结核病防治院中西医结合科，西安 710100
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2026.03.008
  CLC：
- Received：10 October 2024，
  
  Published：25 March 2026
- 稿件说明：
移动端阅览
李彦鹏，景凤英，张燕，等.中药封包联合抗结核药方案治疗结核性腹膜炎疗效及其对炎症介质水平的影响观察［J］.北京中医药，2026，45（3）：328-332.

LI Yanpeng,JING Fengying,ZHANG Yan,et al.Clinical efficacy of Chinese medicine envelope therapy combined with anti-tuberculosis drug regimen in the treatment of tuberculous peritonitis and its effects on the level of inflammatory mediators[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):328-332.
李彦鹏，景凤英，张燕，等.中药封包联合抗结核药方案治疗结核性腹膜炎疗效及其对炎症介质水平的影响观察［J］.北京中医药，2026，45（3）：328-332. DOI： 10.16025/j.1674-1307.2026.03.008.

LI Yanpeng,JING Fengying,ZHANG Yan,et al.Clinical efficacy of Chinese medicine envelope therapy combined with anti-tuberculosis drug regimen in the treatment of tuberculous peritonitis and its effects on the level of inflammatory mediators[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):328-332. DOI： 10.16025/j.1674-1307.2026.03.008.

摘要

目的

探讨中药封包联合抗结核治疗方案对结核性腹膜炎（TBP）患者的效果及其对炎症介质水平的影响。

方法

选取陕西省结核病防治院2022年4月—2023年5月收治的TBP患者170例，采取信封法随机分为对照组、观察组各85例。对照组给予抗结核药物治疗、腹腔穿刺抽液及辅助营养支持等基础治疗，观察组在此基础上联合中药封包辅助治疗。对比2组治疗前后炎症介质［干扰素-γ（IFN-γ）、肿瘤坏死因子-α（TNF-α）、白细胞介素-6（IL-6）、可溶性白细胞介素2受体（SIL-2R）］水平，抽水次数、腹水吸收时间、腹膜厚度，结核病灶吸收情况，疗效及不良反应。

结果

观察组临床疗效优于对照组（

0.05）。治疗后，2组IFN-γ、TNF-α、IL-6、SIL-2R水平均较治疗前降低（

0.05），且观察组低于对照组（

0.01）。与对照组比较，观察组抽水次数少、腹水吸收时间短（

0.01）；2组治疗前腹膜厚度比较差异无统计学意义（

0.05），治疗后观察组腹膜厚度低于对照组（

0.05）。观察组结核病灶吸收有效率高于对照组（

0.05），不良反应发生率低于对照组（

0.05）。

结论

在常规抗结核方案上联合中药封包治疗TBP，能够提高临床疗效，降低炎症介质水平，改善临床症状，降低不良反应发生率。

Abstract

Objective

To investigate the clinical efficacy of Chinese medicine envelope therapy combined with anti-tuberculosis regimen in patients with tuberculous peritonitis （TBP） and its impact on inflammatory mediator levels.

Methods

A total of 170 TBP patients admitted to Shaanxi Provincial Tuberculosis Prevention and Control Hospital from April 2022 to May 2023 were selected and randomly divided into a control group and an observation group， with 85 cases in each group， using the envelope method. The control group received basic treatment including anti-tuberculosis drug therapy， abdominal paracentesis for ascites drainage， and nutritional support. The observation group received Chinese medicine envelope adjuvant therapy in addition to the treatment given to the control group. Inflammatory mediator levels ［interferon-γ （IFN-γ）， tumor necrosis factor-α （TNF-α）， interleukin-6 （IL-6）， and soluble interleukin-2 receptor （sIL-2R）］， number of abdominal paracenteses， ascites absorption time， peritoneal thickness， absorption of tuberculous lesions， clinical efficacy， and adverse reactions were compared between the two groups before and after treatment.

Results

The clinical efficacy in the observation group was superior to that in the control group （

0.05）. After treatment， the le

vels of IFN-γ， TNF-α， IL-6， and sIL-2R in both groups were significantly lower than those before treatment （

0.05）， and were lower in the observation group than in the control group （

0.05）. Compared with the control group， the observation group had fewer paracenteses and shorter ascites absorption time （

0.05）. There was no significant difference in peritoneal thickness between the two groups before treatment （

0.05）， while after treatment， peritoneal thickness in the observation group was lower than that in the control group （

0.05）. The effective absorption rate of tuberculous lesions in the observation group was higher than that in the control group （

0.05）， and the incidence of adverse reactions was lower in the observation group than in the control group （

0.05）.

Conclusion

The combination of Chinese medicine envelope therapy with a conventional anti-tuberculosis regimen in TBP patients can improve clinical efficacy， reduce inflammatory mediator levels， alleviate clinical symptoms， and decrease the incidence of adverse reactions.

关键词

Keywords

references

张云华 , 朱盛华 . 结核性腹膜炎的临床现状及研究进展 [J ] . 中国医学科学院学报 , 2021 , 43 ( 6 ): 975 - 979 .

廖传玉 , 李同心 , 唐神结 , 等 . 高剂量抗结核药物治疗结核病的研究进展 [J ] . 中国感染与化疗杂志 , 2023 , 23 ( 5 ): 639 - 646 .

洪伟玲 , 王潇 , 施静怡 , 等 . 抗结核中药的作用机制研究进展 [J ] . 中医药学报 , 2024 , 52 ( 4 ): 91 - 98 .

易倩 , 付婷婷 . 中药封包联合手法治疗对半月板损伤的疗效观察 [J ] . 成都医学院学报 , 2021 , 16 ( 5 ): 608 - 612 .

王晓 , 陈晓琦 , 赵晴 , 等 . 中药封包联合腹腔注射抗生素治疗原发性肝癌合并自发性腹膜炎 [J ] . 中西医结合肝病杂志 , 2021 , 31 ( 8 ): 688 - 690 .

中国人民解放军总医院第八医学中心结核病医学部 , 《中国防痨杂志》编辑委员会 , 中国医疗保健国际交流促进会结核病学分会基础和临床学部 , 等 . 结核性腹膜炎多学科诊疗专家共识 [J ] . 结核与肺部疾病杂志 , 2025 , 6 ( 2 ): 143 - 157 .

中华中医药学会 . 中医内科常见病诊疗指南中医病证部分 [M ] . 北京 : 中国中医药出版社 , 2008 : 98 - 111 .

贺立山 , 翁孝刚 . 内科学 [M ] . 6版 . 北京 : 人民卫生出版社 , 2005 : 217 .

国家中医药管理局 . 中医病证诊断疗效标准 [M ] . 南京 : 南京大学出版社 , 1994 : 112 - 113 .

罗一婷 , 翁榕星 , 周芳 , 等 . 2019 WHO全球结核报告：全球与中国关键数据分析 [J ] . 新发传染病电子杂志 , 2020 , 5 ( 1 ): 47 - 50 .

裴少君 , 欧喜超 . 世界卫生组织《结核分枝杆菌耐药相关基因突变目录(第2版)》解读 [J ] . 中国防痨杂志 , 2024 , 46 ( 3 ): 260 - 266 .

张蕊 . 中医药治疗结核病的优势和前景 [J ] . 中国民间疗法 , 2023 , 31 ( 15 ): 117 - 120 .

刘建 , 冉莉 , 宋志文 , 等 . 香砂六君子汤结合中药封包治疗抗结核药物致胃肠道反应疗效观察 [J ] . 实用中医药杂志 , 2023 , 39 ( 5 ): 858 - 859 .

张越 , 张选国 , 王靖 , 等 . 中医药治疗肺结核研究进展 [J ] . 河北中医 , 2023 , 45 ( 8 ): 1396 - 1400 .

吴学姣 , 鄢伯钰 , 周绪容 , 等 . 蛇床子素醚类衍生物的合成及抗菌活性 [J ] . 化学研究与应用 , 2022 , 34 ( 7 ): 1532 - 1537 .

毛琼 , 郑凯 . 黄酮类中药单体对溃疡性结肠炎信号通路调控作用的研究进展 [J ] . 环球中医药 , 2024 , 17 ( 4 ): 759 - 768 .

王伟 , 林宇城 , 王玉兰 , 等 . 金银花茯苓提取物对小鼠免疫功能的在体调控作用 [J ] . 沈阳药科大学学报 , 2022 , 39 ( 1 ): 52 - 59 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical efficacy and safety of Guke Xiyao Fumigation treatment for patients with phlegm-fluid abscess type knee synovitis

Clinical effect of Shenyuan Pills on coronary heart disease patients after PCI and its impact on inflammatory responses

Clinical efficacy of Liangxue Wuhua Decoction combined with tacrolimus ointment in treatment of facial corticosteroid-dependent dermatitis

Safety of supranormal dose of Scutellaria barbata and Hedyotis diffusa in treating malignant tumor: a retrospective cohort study

Clinical efficacy of Shengxuebao Mixture in treatment of mice with gastric cancer anemia caused by cyclophosphamide

Related Author

LIU Qingquan

WEI Hongyu

SUN Peiyu

LIU Genzhe

ZHANG Shuo

CHE Fangyuan

HUANG Ximan

WANG Wei

Related Institution

Beijing University of Chinese Medicine

Orthopedics Department， Beijing Hospital of Traditional Chinese Medicine， Capital Medical University

Beijing Institute of Traditional Chinese Medicine

Department of Cardiovascular Medicine， Shunyi Hospital of Beijing Hospital of Traditional Chinese Medicine

Department of Cardiovascular Medicine， Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

⁰